| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $23.1M | -30.6% |
| SG&A Expense | $8.8M | -23.4% |
| Operating Income | -$32.2M | +28.6% |
| Interest Expense | $2.9M | -32.7% |
| Net Income | -$32.1M | +36.1% |
| EPS (Basic) | -$7.30 | -371.0% |
| EPS (Diluted) | -$7.30 | -371.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.8M | +22.5% |
| Current Assets | $24.0M | -29.4% |
| Total Assets | $25.2M | -28.2% |
| Current Liabilities | $9.4M | -35.5% |
| Total Liabilities | $9.7M | -50.9% |
| Stockholders' Equity | $15.5M | +1.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.9M | +30.6% |
| Investing Cash Flow | $14.5M | +201.6% |
| Financing Cash Flow | $17.8M | -67.8% |